Macquarie Group’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $10.9M | Buy |
17,532
+4,482
| +34% | +$3.05M | 0.05% | 266 |
|
|
2026
Q1 | $10.1M | Sell |
13,050
-20,767
| -61% | -$15.9M | 0.06% | 233 |
|
|
2025
Q4 | $26.1M | Sell |
33,817
-52,851
| -61% | -$35.9M | 0.11% | 152 |
|
|
2025
Q3 | $48.7M | Buy |
86,668
+9,943
| +13% | +$5.62M | 0.06% | 430 |
|
|
2025
Q2 | $40.3M | Sell |
76,725
-2,113
| -3% | -$1.18M | 0.05% | 475 |
|
|
2025
Q1 | $50M | Sell |
78,838
-175
| -0.2% | -$120K | 0.06% | 406 |
|
|
2024
Q4 | $53.4M | Buy |
79,013
+3,872
| +5% | +$3.25M | 0.06% | 398 |
|
|
2024
Q3 | $79M | Sell |
75,141
-1,284
| -2% | -$1.43M | 0.09% | 322 |
|
|
2024
Q2 | $80.3M | Sell |
76,425
-423
| -0.6% | -$410K | 0.09% | 282 |
|
|
2024
Q1 | $74M | Sell |
76,848
-1,890
| -2% | -$1.8M | 0.08% | 311 |
|
|
2023
Q4 | $69.2M | Sell |
78,738
-23,013
| -23% | -$19M | 0.08% | 346 |
|
|
2023
Q3 | $83.7M | Buy |
101,751
+498
| +0.5% | +$391K | 0.11% | 262 |
|
|
2023
Q2 | $72.8M | Sell |
101,253
-69,846
| -41% | -$53.9M | 0.08% | 319 |
|
|
2023
Q1 | $141M | Sell |
171,099
-68,587
| -29% | -$51.7M | 0.17% | 159 |
|
|
2022
Q4 | $173M | Sell |
239,686
-18,887
| -7% | -$13.9M | 0.2% | 115 |
|
|
2022
Q3 | $178M | Sell |
258,573
-20,339
| -7% | -$12.8M | 0.22% | 99 |
|
|
2022
Q2 | $165M | Sell |
278,912
-5,396
| -2% | -$3.51M | 0.19% | 127 |
|
|
2022
Q1 | $199M | Buy |
284,308
+10,575
| +4% | +$6.69M | 0.15% | 135 |
|
|
2021
Q4 | $173M | Buy |
273,733
+55,802
| +26% | +$34.3M | 0.14% | 181 |
|
|
2021
Q3 | $132M | Buy |
217,931
+111,854
| +105% | +$69.4M | 0.11% | 237 |
|
|
2021
Q2 | $59.2M | Buy |
106,077
+2,865
| +3% | +$1.45M | 0.05% | 482 |
|
|
2021
Q1 | $48.8M | Buy |
103,212
+862
| +0.8% | +$420K | 0.07% | 338 |
|
|
2020
Q4 | $49.4M | Buy |
102,350
+4,164
| +4% | +$2.25M | 0.07% | 316 |
|
|
2020
Q3 | $55M | Buy |
98,186
+4,356
| +5% | +$2.64M | 0.09% | 237 |
|
|
2020
Q2 | $58.5M | Buy |
93,830
+10,174
| +12% | +$5.77M | 0.1% | 224 |
|
|
2020
Q1 | $40.8M | Sell |
83,656
-21,574
| -21% | -$8.9M | 0.08% | 255 |
|
|
2019
Q4 | $39.5M | Sell |
105,230
-191
| -0.2% | -$64.3K | 0.06% | 353 |
|
|
2019
Q3 | $29.2M | Buy |
105,421
+28,000
| +36% | +$8.29M | 0.05% | 375 |
|
|
2019
Q2 | $24.2M | Buy |
77,421
+10,877
| +16% | +$3.62M | 0.04% | 416 |
|
|
2019
Q1 | $27.3M | Sell |
66,544
-17,816
| -21% | -$7.34M | 0.05% | 396 |
|
|
2018
Q4 | $31.5M | Buy |
84,360
+14,030
| +20% | +$5.14M | 0.06% | 318 |
|
|
2018
Q3 | $28.4M | Buy |
70,330
+2,790
| +4% | +$1.06M | 0.05% | 397 |
|
|
2018
Q2 | $23.3M | Buy |
67,540
+5,593
| +9% | +$1.75M | 0.04% | 443 |
|
|
2018
Q1 | $21.3M | Buy |
61,947
+7,823
| +14% | +$2.72M | 0.04% | 447 |
|
|
2017
Q4 | $20.1M | Buy |
54,124
+27,393
| +102% | +$11.1M | 0.04% | 474 |
|
|
2017
Q3 | $12M | Sell |
26,731
-4,877
| -15% | -$2.32M | 0.02% | 571 |
|
|
2017
Q2 | $15.5M | Buy |
31,608
+513
| +2% | +$224K | 0.03% | 505 |
|
|
2017
Q1 | $12.1M | Sell |
31,095
-7,890
| -20% | -$2.92M | 0.02% | 574 |
|
|
2016
Q4 | $14.3M | Sell |
38,985
-52
| -0.1% | -$19.8K | 0.03% | 527 |
|
|
2016
Q3 | $15.7M | Buy |
39,037
+3,823
| +11% | +$1.53M | 0.03% | 491 |
|
|
2016
Q2 | $12.3M | Buy |
35,214
+2,514
| +8% | +$968K | 0.02% | 517 |
|
|
2016
Q1 | $11.8M | Sell |
32,700
-6,250
| -16% | -$2.58M | 0.02% | 504 |
|
|
2015
Q4 | $21.1M | Sell |
38,950
-1,200
| -3% | -$650K | 0.04% | 337 |
|
|
2015
Q3 | $18.7M | Buy |
40,150
+4,750
| +13% | +$2.55M | 0.04% | 356 |
|
|
2015
Q2 | $18.1M | Hold |
35,400
| – | – | 0.04% | 382 |
|
|
2015
Q1 | $16M | Buy |
35,400
+100
| +0.3% | +$42.4K | 0.03% | 430 |
|
|
2014
Q4 | $14.5M | Buy |
35,300
+4,100
| +13% | +$1.61M | 0.03% | 443 |
|
|
2014
Q3 | $11.2M | Buy |
31,200
+2,000
| +7% | +$670K | 0.02% | 480 |
|
|
2014
Q2 | $8.25M | Sell |
29,200
-1,500
| -5% | -$445K | 0.02% | 554 |
|
|
2014
Q1 | $9.22M | Buy |
30,700
+4,700
| +18% | +$1.45M | 0.02% | 518 |
|
|
2013
Q4 | $7.16M | Buy |
26,000
+1,100
| +4% | +$316K | 0.01% | 552 |
|
|
2013
Q3 | $7.79M | Hold |
24,900
| – | – | 0.02% | 509 |
|
|
2013
Q2 | $5.6M | Buy |
+24,900
| New | +$5.8M | 0.01% | 563 |
|
Other funds holding REGN
Macquarie Group's REGN Position: Q2 2026 in Review
Macquarie Group increased its Regeneron Pharmaceuticals (REGN) stake by 34% in Q2 2026, buying an estimated $3.05M and bringing the position to 17,532 shares worth $10.9M. The position accounts for 0.05% of the portfolio, ranked #266.
Macquarie Group first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $199M in Q1 2022. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- Macquarie Group held 17,532 shares of Regeneron Pharmaceuticals worth $10.9M as of Q2 2026.
- Macquarie Group bought 4,482 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $3.05M.
- Regeneron Pharmaceuticals made up 0.05% of Macquarie Group's portfolio in Q2 2026, its #266 holding.
- Macquarie Group first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
- Macquarie Group's Regeneron Pharmaceuticals position peaked at $199M in Q1 2022.
- 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on Macquarie Group's 13F filing for Q2 2026, filed 14 Aug 2026.